A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching
Agnès Devergie,J. F. Apperley,M. Labopin,Alejandro Madrigal,Niels Jacobsen,Enric Carreras,H. G. Prentice,Jean-Pierre Jouet,Kolb Hj,B. Herstenstein,Almalina Bacigalupo,Stein A. Evensen,Per Ljungman,T. de Witte,Josy Reiffers,Arnon Nagler,Richard E. Clark,J. M. Goldman,Alois Gratwohl +18 more
TL;DR: A ‘good risk’ group is defined, ie patients transplanted in first chronic phase, from an HLA-DRB1 matched donor, without TCD as prophylaxis against GVHD, suggesting that the long-term outcome of patients with favorable prognostic features can approach that of patients transplants from geno-identical siblings.
Journal ArticleDOI
Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: A survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Sebastian Giebel,Leszek Miszczyk,Krzysztof Slosarek,Leila Moukhtari,Fabio Ciceri,Jordi Esteve,Norbert Claude Gorin,Myriam Labopin,Arnon Nagler,Christoph Schmid,Mohamad Mohty +10 more
TL;DR: Current clinical practice in total body irradiation for conditioning before hematopoietic cell transplantation is explored to explore its efficacy and toxicity.
Journal ArticleDOI
Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis.
TL;DR: The results demonstrate the important role of collagen type I in tumor angiogenesis and tumor growth and implicate its role in chronic wounds and provide an attractive new target for cancer therapy.
Journal ArticleDOI
Interaction between CXCR4 and CCL20 pathways regulates tumor growth.
Katia Beider,Michal Abraham,Michal Begin,Hanna Wald,Ido D. Weiss,Ori Wald,Eli Pikarsky,Rinat Abramovitch,Evelyne Zeira,Eithan Galun,Arnon Nagler,Amnon Peled +11 more
TL;DR: A role for CCL20 is revealed in CXCR4-dependent and -independent tumor growth and a therapeutic potential for C CL20 and CCR6 antagonists in the treatment of CX CR4- and CCL 20-dependent malignancies is suggested.
Journal ArticleDOI
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Catherine J. Lee,Bipin N. Savani,Mohamad Mohty,Myriam Labopin,Annalisa Ruggeri,Christoph Schmid,Frédéric Baron,Jordi Esteve,Norbert Claude Gorin,Sebastian Giebel,Fabio Ciceri,Arnon Nagler +11 more
TL;DR: The transformative changes in haploidentical hematopoietic cell transplantation techniques over the past decade are described, which have led to the current widespread use of this procedure.